INmune Bio Inc - ESG Rating & Company Profile powered by AI
This ESG score for INmune Bio Inc indicates the company's reporting of the UN Sustainable Development Goals. If you work at INmune Bio Inc and you would like to licence your ESG rating, please get in touch. Check the bottom of this webpage for potential risks for INmune Bio Inc based on sector, location and size.
INmune Bio Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.2; made up of an environmental score of 2.7, social score of 4.8 and governance score of 2.0.
3.2
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1253 | Stallergenes Greer Ltd | 3.3 | Medium |
| 1253 | Zynerba Pharmaceuticals Inc | 3.3 | Medium |
| 1299 | INmune Bio Inc | 3.2 | Medium |
| 1299 | Acreage Holdings Inc | 3.2 | Medium |
| 1299 | Advicenne SA | 3.2 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does INmune Bio Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes INmune Bio Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes INmune Bio Inc report the average age of the workforce?
Sign up for free to unlockDoes INmune Bio Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes INmune Bio Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes INmune Bio Inc disclose cybersecurity risks?
Sign up for free to unlockDoes INmune Bio Inc offer flexible work?
Sign up for free to unlockDoes INmune Bio Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes INmune Bio Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes INmune Bio Inc conduct supply chain audits?
Sign up for free to unlockDoes INmune Bio Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes INmune Bio Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes INmune Bio Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes INmune Bio Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes INmune Bio Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes INmune Bio Inc disclose water use targets?
Sign up for free to unlockDoes INmune Bio Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid INmune Bio Inc have a product recall in the last two years?
Sign up for free to unlockDoes INmune Bio Inc disclose incidents of discrimination?
Sign up for free to unlockDoes INmune Bio Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas INmune Bio Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes INmune Bio Inc disclose parental leave metrics?
Sign up for free to unlockDoes INmune Bio Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes INmune Bio Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes INmune Bio Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes INmune Bio Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes INmune Bio Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes INmune Bio Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs INmune Bio Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes INmune Bio Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes INmune Bio Inc disclose its waste policy?
Sign up for free to unlockDoes INmune Bio Inc report according to TCFD requirements?
Sign up for free to unlockDoes INmune Bio Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes INmune Bio Inc disclose energy use targets?
Sign up for free to unlockDoes INmune Bio Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes INmune Bio Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for INmune Bio Inc
These potential risks are based on the size, segment and geographies of the company.
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03, an immunotherapy that treats patients with hematologic malignancies and solid tumors; and XPro1595 for the treatment of Alzheimer's disease. The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.